Results 31 to 40 of about 2,430 (167)

Personalized Therapeutics for KATP-Dependent Pathologies. [PDF]

open access: yesAnnu Rev Pharmacol Toxicol, 2023
Nichols CG.
europepmc   +1 more source

3-(6-Bromo-4-oxo-4H-chromen-3-yl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-1,1-dione [PDF]

open access: gold, 2010
Mariya al-Rashida   +4 more
openalex   +1 more source

CDK4: a master regulator of the cell cycle and its role in cancer. [PDF]

open access: yesGenes Cancer, 2022
Baker SJ   +4 more
europepmc   +1 more source

3-(6-Fluoro-4-oxo-4H-chromen-3-yl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-1,1-dione [PDF]

open access: gold, 2010
Mariya al‐Rashida   +4 more
openalex   +1 more source

High-Throughput Phenotypic Screening and Machine Learning Methods Enabled the Selection of Broad-Spectrum Low-Toxicity Antitrypanosomatidic Agents. [PDF]

open access: yesJ Med Chem, 2023
Linciano P   +21 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy